Stanford study offers hope to CAR T-cell therapy relapsed B cell lymphoma patients
In a small study, half of the patients whose lymphoma failed to respond to all previous treatments including CAR T-cell therapy, responded
Combination treatment boosts lasting remission in B-cell Lymphoma
CANCER DIGEST – June 23, 2024 – A non-chemotherapy regimen has achieved a significant improvement in long-term remissions.
